Craniofacial resection for malignant paranasal sinus tumors: Report of an International Collaborative Study

Abstract

CFR for malignant paranasal sinus tumors is a safe surgical treatment with an overall mortality of 4.5% and complication rate of 33%. The status of surgical margins, histologic findings of the primary tumor, and intracranial extent are independent predictors of outcome.